Profiles

Keywords
Last Name
Institution
 Back to Profile

Rami Doukky

Concepts (381)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myocardial Perfusion Imaging
48
2023
71
22.830
 Why?
Tomography, Emission-Computed, Single-Photon
43
2023
94
14.350
 Why?
Coronary Artery Disease
26
2023
173
13.790
 Why?
Purines
21
2020
33
10.270
 Why?
Pyrazoles
22
2020
53
10.140
 Why?
Myocardial Ischemia
14
2020
64
6.990
 Why?
Kidney Failure, Chronic
12
2023
188
6.060
 Why?
Exercise Test
23
2020
133
5.510
 Why?
Myocardial Infarction
14
2023
194
5.320
 Why?
Thrombosis
10
2022
74
4.930
 Why?
Kidney Transplantation
7
2023
153
4.410
 Why?
Adenosine A2 Receptor Agonists
10
2019
11
4.350
 Why?
Prognosis
34
2023
1011
4.040
 Why?
Atrial Fibrillation
13
2022
234
3.900
 Why?
Aminophylline
9
2018
9
3.490
 Why?
Heart Failure
14
2022
241
3.260
 Why?
Humans
132
2023
32988
3.110
 Why?
Heart Diseases
5
2021
104
2.780
 Why?
Middle Aged
61
2022
11219
2.780
 Why?
Renal Insufficiency, Chronic
5
2021
113
2.770
 Why?
Risk Assessment
22
2021
814
2.640
 Why?
Male
74
2023
17726
2.600
 Why?
Female
75
2023
18423
2.510
 Why?
Atrial Appendage
8
2022
53
2.360
 Why?
Echocardiography, Transesophageal
6
2019
53
2.340
 Why?
Patient Selection
7
2021
261
2.310
 Why?
Liver Transplantation
4
2021
112
2.300
 Why?
Risk Factors
34
2023
2762
2.290
 Why?
Vasodilator Agents
9
2018
35
2.130
 Why?
Cardiology
9
2020
115
2.110
 Why?
Retrospective Studies
32
2023
3835
2.100
 Why?
Aged
48
2022
10542
2.050
 Why?
Heart
7
2023
119
2.020
 Why?
Stroke Volume
9
2022
67
2.020
 Why?
Electrocardiography
6
2018
230
1.900
 Why?
Predictive Value of Tests
17
2021
626
1.870
 Why?
Coronary Angiography
8
2023
115
1.800
 Why?
Death, Sudden, Cardiac
4
2015
33
1.780
 Why?
Pulmonary Embolism
5
2022
58
1.710
 Why?
Heart Rate
3
2017
165
1.660
 Why?
Echocardiography
9
2023
207
1.630
 Why?
Reproducibility of Results
15
2019
893
1.590
 Why?
Natriuretic Peptide, Brain
4
2021
12
1.580
 Why?
Diagnostic Imaging
3
2021
101
1.540
 Why?
Prospective Studies
19
2020
2002
1.500
 Why?
Mitral Valve
3
2020
20
1.380
 Why?
Percutaneous Coronary Intervention
4
2022
31
1.380
 Why?
Sensitivity and Specificity
12
2018
592
1.340
 Why?
Nuclear Medicine
5
2019
11
1.300
 Why?
Ventricular Dysfunction, Left
3
2022
55
1.260
 Why?
Randomized Controlled Trials as Topic
12
2022
377
1.250
 Why?
Drug-Eluting Stents
3
2022
15
1.230
 Why?
Cardiovascular Diseases
6
2021
446
1.200
 Why?
Unnecessary Procedures
3
2015
29
1.200
 Why?
Coronary Stenosis
2
2018
17
1.180
 Why?
Troponin I
2
2017
21
1.180
 Why?
Heart-Assist Devices
4
2019
32
1.170
 Why?
Transcatheter Aortic Valve Replacement
6
2023
33
1.170
 Why?
Multimodal Imaging
3
2021
30
1.160
 Why?
Heart Valve Prosthesis Implantation
4
2023
53
1.120
 Why?
Ventricular Function, Left
5
2020
63
1.100
 Why?
Ventricular Dysfunction, Right
3
2021
16
1.100
 Why?
Treatment Outcome
27
2023
4036
1.040
 Why?
United States
17
2023
2632
1.020
 Why?
Heart Valve Diseases
3
2020
33
1.010
 Why?
Angina Pectoris
2
2023
18
1.010
 Why?
Diarrhea
3
2012
49
1.000
 Why?
Comorbidity
9
2021
563
0.990
 Why?
Aortic Valve Stenosis
5
2023
33
0.960
 Why?
Heart Ventricles
3
2021
225
0.960
 Why?
Aortic Valve Insufficiency
2
2023
11
0.940
 Why?
Incidence
9
2020
840
0.940
 Why?
Chicago
10
2019
957
0.910
 Why?
Insurance Coverage
2
2020
20
0.880
 Why?
Medicaid
2
2020
43
0.870
 Why?
Platelet Aggregation Inhibitors
4
2022
68
0.850
 Why?
Medicare
2
2019
129
0.820
 Why?
Hematoma
1
2021
25
0.820
 Why?
Calcium
3
2021
531
0.810
 Why?
Cardiomyopathies
3
2020
38
0.810
 Why?
Coronary Vessels
1
2021
56
0.800
 Why?
Follow-Up Studies
10
2019
2053
0.800
 Why?
Image Enhancement
2
2018
61
0.800
 Why?
Double-Blind Method
7
2016
546
0.800
 Why?
Diltiazem
1
2020
5
0.780
 Why?
Atrioventricular Node
1
2020
7
0.780
 Why?
Cohort Studies
10
2020
2077
0.780
 Why?
Antihypertensive Agents
2
2022
93
0.780
 Why?
Survival Rate
6
2017
443
0.780
 Why?
Hyperkalemia
1
2020
7
0.780
 Why?
Bradycardia
1
2020
32
0.770
 Why?
Primary Health Care
2
2013
107
0.760
 Why?
Critical Pathways
2
2017
22
0.750
 Why?
Patient Protection and Affordable Care Act
1
2020
26
0.750
 Why?
Decision Support Systems, Clinical
1
2019
12
0.740
 Why?
Tissue Survival
1
2019
3
0.740
 Why?
Adult
15
2020
9848
0.740
 Why?
Multidetector Computed Tomography
2
2021
12
0.740
 Why?
Severity of Illness Index
8
2020
1242
0.740
 Why?
Acute Coronary Syndrome
1
2019
15
0.730
 Why?
Calcinosis
1
2020
53
0.730
 Why?
Defibrillators, Implantable
1
2020
41
0.730
 Why?
Syncope
1
2019
11
0.730
 Why?
Bundle-Branch Block
1
2019
18
0.710
 Why?
Esophageal and Gastric Varices
1
2019
2
0.710
 Why?
Cardiac Tamponade
1
2018
6
0.700
 Why?
Echocardiography, Doppler
2
2016
30
0.700
 Why?
Decision Support Techniques
1
2019
57
0.700
 Why?
Artificial Intelligence
1
2019
26
0.690
 Why?
Oximetry
1
2018
14
0.690
 Why?
Aged, 80 and over
13
2022
5249
0.680
 Why?
Arrhythmias, Cardiac
1
2020
172
0.670
 Why?
Pericardial Effusion
1
2018
6
0.670
 Why?
Aortic Valve
5
2023
44
0.660
 Why?
Myocardium
2
2019
178
0.650
 Why?
Contrast Media
1
2018
148
0.650
 Why?
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography
1
2017
1
0.620
 Why?
Cardiac Imaging Techniques
1
2017
8
0.620
 Why?
Radiopharmaceuticals
4
2020
57
0.620
 Why?
Preoperative Care
2
2015
148
0.610
 Why?
Accreditation
1
2016
18
0.600
 Why?
Purinergic P1 Receptor Antagonists
2
2013
2
0.590
 Why?
Neoplasms, Radiation-Induced
1
2016
15
0.570
 Why?
Hemodynamics
1
2016
100
0.570
 Why?
Diet, Sodium-Restricted
1
2016
8
0.570
 Why?
Cardio-Renal Syndrome
1
2015
1
0.570
 Why?
Prevalence
7
2023
554
0.570
 Why?
Hospitalization
6
2021
367
0.570
 Why?
Guideline Adherence
4
2019
78
0.560
 Why?
Sexism
1
2015
9
0.550
 Why?
Insurance Carriers
1
2015
3
0.550
 Why?
Adenosine
1
2015
16
0.550
 Why?
Technetium
1
2015
7
0.540
 Why?
Cardiotonic Agents
4
2018
18
0.540
 Why?
Registries
4
2023
226
0.540
 Why?
Hospital Mortality
5
2021
197
0.530
 Why?
Perfusion
4
2023
24
0.530
 Why?
Social Class
1
2015
77
0.530
 Why?
End Stage Liver Disease
1
2014
18
0.520
 Why?
Physicians' Offices
2
2013
5
0.520
 Why?
Myocardial Revascularization
4
2020
25
0.520
 Why?
Rheumatic Heart Disease
1
2014
1
0.510
 Why?
Hyperemia
1
2014
3
0.500
 Why?
Echocardiography, Stress
1
2014
5
0.500
 Why?
Thrombophilia
1
2014
9
0.500
 Why?
Hyperthyroidism
1
2014
18
0.500
 Why?
Emigrants and Immigrants
1
2014
25
0.500
 Why?
Thromboembolism
1
2014
38
0.480
 Why?
Heart Failure, Systolic
1
2013
6
0.480
 Why?
Cross-Sectional Studies
8
2020
1058
0.480
 Why?
Technetium Tc 99m Sestamibi
3
2019
12
0.470
 Why?
Pulmonary Disease, Chronic Obstructive
1
2014
45
0.470
 Why?
Women's Health
1
2015
247
0.470
 Why?
Diabetes Complications
1
2013
70
0.460
 Why?
Urban Population
1
2014
164
0.460
 Why?
Kaplan-Meier Estimate
4
2018
216
0.460
 Why?
Renal Dialysis
3
2019
132
0.460
 Why?
Dizziness
1
2012
18
0.460
 Why?
Lung
1
2014
179
0.460
 Why?
Angina, Unstable
2
2002
12
0.440
 Why?
Abdominal Pain
1
2012
9
0.440
 Why?
Physicians
1
2014
136
0.430
 Why?
Algorithms
3
2019
428
0.430
 Why?
Sex Distribution
3
2016
92
0.420
 Why?
Odds Ratio
4
2018
321
0.420
 Why?
Exercise
1
2016
494
0.400
 Why?
Chi-Square Distribution
3
2018
177
0.400
 Why?
Patient Positioning
1
2011
39
0.400
 Why?
Multivariate Analysis
3
2018
386
0.390
 Why?
Periodicals as Topic
3
2020
47
0.390
 Why?
Time Factors
6
2019
1873
0.390
 Why?
Positron-Emission Tomography
4
2019
102
0.380
 Why?
Ambulatory Care
1
2010
85
0.380
 Why?
Utilization Review
3
2020
7
0.370
 Why?
Practice Guidelines as Topic
5
2017
388
0.360
 Why?
Thallium Radioisotopes
2
2019
6
0.350
 Why?
Troponin
3
2021
11
0.330
 Why?
Radionuclide Imaging
2
2020
59
0.330
 Why?
Acute Disease
3
2021
258
0.320
 Why?
Glomerular Filtration Rate
2
2020
77
0.310
 Why?
Risk
3
2020
228
0.310
 Why?
Drug Administration Schedule
3
2018
249
0.310
 Why?
Stroke
3
2022
405
0.300
 Why?
Benchmarking
2
2023
42
0.290
 Why?
Image Processing, Computer-Assisted
2
2019
234
0.280
 Why?
Causality
2
2016
60
0.280
 Why?
Age Distribution
2
2016
109
0.280
 Why?
Feasibility Studies
5
2022
282
0.280
 Why?
Chronic Disease
3
2019
554
0.270
 Why?
Propensity Score
2
2016
56
0.270
 Why?
ROC Curve
2
2016
155
0.270
 Why?
Proportional Hazards Models
3
2018
387
0.270
 Why?
Administration, Intravenous
2
2016
35
0.270
 Why?
Illinois
3
2021
267
0.270
 Why?
Logistic Models
2
2018
474
0.270
 Why?
Point-of-Care Systems
2
2018
30
0.260
 Why?
Patient Compliance
2
2017
200
0.260
 Why?
Syndrome
2
2023
101
0.250
 Why?
Decision Making
2
2017
239
0.250
 Why?
Cause of Death
2
2015
83
0.240
 Why?
Dyspnea
1
2023
39
0.230
 Why?
Placebo Effect
2
2014
26
0.230
 Why?
Hypotension
1
2022
30
0.230
 Why?
Journal Impact Factor
2
2020
16
0.230
 Why?
Pericardium
2
2021
30
0.230
 Why?
Ultrasonography
2
2014
215
0.220
 Why?
Pulmonary Veins
1
2022
25
0.220
 Why?
Anticoagulants
3
2022
153
0.220
 Why?
Pilot Projects
3
2014
466
0.220
 Why?
Coronary Artery Bypass
1
2022
74
0.210
 Why?
Magnetic Resonance Imaging, Cine
1
2021
13
0.210
 Why?
Technetium Tc 99m Pyrophosphate
1
2020
1
0.200
 Why?
Amyloid Neuropathies, Familial
1
2020
3
0.200
 Why?
Patient Discharge
2
2019
169
0.200
 Why?
Ischemia
1
2020
35
0.190
 Why?
Electric Countershock
1
2020
30
0.190
 Why?
Adipose Tissue
1
2021
99
0.190
 Why?
Sample Size
1
2019
26
0.190
 Why?
Mobile Applications
1
2020
36
0.190
 Why?
Ventriculography, First-Pass
1
2019
1
0.190
 Why?
Prospective Payment System
1
2019
4
0.190
 Why?
Sex Characteristics
1
2021
139
0.190
 Why?
Thrombocytopenia
1
2019
31
0.180
 Why?
Inpatients
2
2019
163
0.180
 Why?
Intermittent Pneumatic Compression Devices
1
2019
7
0.180
 Why?
Health Resources
1
2019
28
0.180
 Why?
Mitral Valve Insufficiency
1
2019
13
0.180
 Why?
Publication Bias
1
2019
7
0.180
 Why?
Asymptomatic Diseases
1
2019
21
0.180
 Why?
Electrodes, Implanted
1
2019
51
0.180
 Why?
Writing
1
2019
23
0.180
 Why?
Cardiac Resynchronization Therapy
1
2019
24
0.180
 Why?
Models, Statistical
1
2019
145
0.180
 Why?
Outpatients
1
2019
60
0.180
 Why?
Antidotes
1
2018
6
0.180
 Why?
Multicenter Studies as Topic
1
2019
78
0.180
 Why?
Medication Adherence
2
2020
94
0.180
 Why?
Angioplasty, Balloon
1
2019
28
0.180
 Why?
Pericardial Window Techniques
1
2018
3
0.180
 Why?
Sphygmomanometers
1
2018
3
0.180
 Why?
Plethysmography
1
2018
5
0.180
 Why?
Pericardiocentesis
1
2018
4
0.180
 Why?
Vasodilation
1
2018
21
0.170
 Why?
Death
2
2022
48
0.170
 Why?
Coronary Circulation
1
2018
49
0.170
 Why?
Hypertension, Pulmonary
1
2019
27
0.170
 Why?
Angioplasty, Balloon, Coronary
2
2013
52
0.170
 Why?
Guidelines as Topic
1
2019
78
0.170
 Why?
Cardiac Pacing, Artificial
1
2019
84
0.170
 Why?
Heart Atria
1
2019
97
0.170
 Why?
Respiration
1
2018
37
0.170
 Why?
Hypocalcemia
1
2018
4
0.170
 Why?
Hospitals
1
2019
159
0.170
 Why?
Kidney
1
2020
219
0.170
 Why?
Hospice Care
1
2019
36
0.170
 Why?
Hypercalcemia
1
2018
12
0.170
 Why?
Cardiac Surgical Procedures
1
2019
104
0.170
 Why?
Tachycardia
1
2018
49
0.170
 Why?
Evidence-Based Medicine
2
2014
235
0.170
 Why?
Angina, Stable
1
2017
2
0.160
 Why?
Young Adult
2
2016
2287
0.160
 Why?
Potassium
1
2018
72
0.160
 Why?
Chest Pain
1
2017
23
0.160
 Why?
Research Design
1
2019
244
0.160
 Why?
Kidney Function Tests
1
2017
28
0.160
 Why?
Patient Readmission
1
2019
134
0.160
 Why?
Central Venous Pressure
1
2017
6
0.160
 Why?
Physician-Patient Relations
1
2017
47
0.160
 Why?
Arterial Pressure
1
2017
16
0.150
 Why?
Palliative Care
1
2019
158
0.150
 Why?
Veterans
1
2019
96
0.150
 Why?
Internship and Residency
1
2020
209
0.150
 Why?
Patient Safety
1
2017
55
0.150
 Why?
Organophosphorus Compounds
1
2016
7
0.150
 Why?
Organotechnetium Compounds
1
2016
10
0.150
 Why?
Regression Analysis
2
2015
326
0.150
 Why?
Perfusion Imaging
1
2016
14
0.150
 Why?
Radiation Protection
1
2016
8
0.150
 Why?
Area Under Curve
1
2016
77
0.140
 Why?
Disease Management
1
2017
138
0.140
 Why?
Lipoprotein(a)
1
2016
10
0.140
 Why?
Directive Counseling
1
2016
15
0.140
 Why?
Hospitals, High-Volume
1
2015
10
0.140
 Why?
Sympathetic Nervous System
1
2015
14
0.140
 Why?
Dyslipidemias
1
2016
28
0.140
 Why?
Workload
1
2015
39
0.140
 Why?
Single-Blind Method
1
2015
130
0.140
 Why?
Sex Factors
2
2016
548
0.140
 Why?
Pattern Recognition, Automated
1
2015
11
0.140
 Why?
Diagnostic Errors
1
2015
48
0.140
 Why?
Rest
1
2015
32
0.130
 Why?
Health Services Misuse
1
2015
3
0.130
 Why?
Self Care
1
2016
105
0.130
 Why?
Age Factors
2
2018
932
0.130
 Why?
Computer Communication Networks
1
2014
5
0.130
 Why?
Population Groups
1
2014
5
0.130
 Why?
Self Report
1
2016
245
0.130
 Why?
Robotics
1
2014
19
0.130
 Why?
Gastrointestinal Tract
1
2014
56
0.130
 Why?
Remote Consultation
1
2014
16
0.130
 Why?
Cost-Benefit Analysis
1
2015
159
0.130
 Why?
Surgeons
1
2015
98
0.120
 Why?
Dilatation
1
2013
13
0.120
 Why?
Disease-Free Survival
1
2013
228
0.110
 Why?
Infusions, Intravenous
1
2012
87
0.110
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2012
34
0.110
 Why?
Adenosine A2 Receptor Antagonists
1
2012
1
0.110
 Why?
Premedication
1
2012
6
0.110
 Why?
Injections, Intravenous
1
2012
60
0.110
 Why?
Drug Interactions
1
2012
70
0.110
 Why?
Diagnosis, Differential
1
2013
462
0.110
 Why?
Supine Position
1
2011
18
0.100
 Why?
Asthma
1
2014
194
0.100
 Why?
Safety
1
2010
55
0.100
 Why?
Diastole
1
2010
35
0.090
 Why?
Administration, Oral
2
2022
158
0.090
 Why?
Hemorrhage
2
2022
95
0.090
 Why?
Child
1
2014
1634
0.090
 Why?
Internet
2
2020
112
0.080
 Why?
Body Mass Index
1
2011
478
0.080
 Why?
Aging
1
2018
1634
0.080
 Why?
Adolescent
1
2014
2687
0.080
 Why?
Diabetes Mellitus, Type 2
1
2010
230
0.080
 Why?
Equipment Design
2
2019
207
0.070
 Why?
Receptors, Angiotensin
1
2022
2
0.060
 Why?
Neprilysin
1
2022
9
0.060
 Why?
Equipment Failure
1
2023
56
0.060
 Why?
Angiotensin Receptor Antagonists
1
2022
11
0.060
 Why?
Magnetic Resonance Imaging
2
2019
1315
0.060
 Why?
Lasers
1
2022
17
0.060
 Why?
Bayes Theorem
1
2022
49
0.060
 Why?
Angiotensin-Converting Enzyme Inhibitors
1
2022
32
0.060
 Why?
Hematologic Agents
1
2002
4
0.060
 Why?
Vitamin K
1
2022
11
0.060
 Why?
Drug Therapy, Combination
1
2022
261
0.050
 Why?
Fibrinolytic Agents
1
2022
96
0.050
 Why?
Peptide Fragments
1
2021
118
0.050
 Why?
Lost to Follow-Up
1
2019
2
0.050
 Why?
Fellowships and Scholarships
1
2020
44
0.050
 Why?
Data Interpretation, Statistical
1
2019
99
0.050
 Why?
Editorial Policies
1
2019
7
0.050
 Why?
Peer Review, Research
1
2019
10
0.040
 Why?
Authorship
1
2019
16
0.040
 Why?
Endpoint Determination
1
2019
31
0.040
 Why?
Quality Control
1
2019
52
0.040
 Why?
Bibliometrics
1
2019
23
0.040
 Why?
Cardiovascular Agents
1
2019
33
0.040
 Why?
Congresses as Topic
1
2019
36
0.040
 Why?
American Heart Association
1
2019
39
0.040
 Why?
Hospital Costs
1
2019
74
0.040
 Why?
Checklist
1
2019
43
0.040
 Why?
Veterans Health
1
2018
3
0.040
 Why?
United States Department of Veterans Affairs
1
2018
11
0.040
 Why?
Protective Factors
1
2018
19
0.040
 Why?
Software
1
2018
77
0.040
 Why?
Intensive Care Units
1
2021
339
0.040
 Why?
Research Report
1
2017
11
0.040
 Why?
Databases, Factual
1
2019
393
0.040
 Why?
Length of Stay
1
2019
382
0.040
 Why?
Pyridones
1
2016
18
0.040
 Why?
Thiazoles
1
2016
38
0.040
 Why?
Pyridines
1
2016
47
0.040
 Why?
Mortality
1
2017
96
0.040
 Why?
Georgia
1
2016
16
0.040
 Why?
Warfarin
1
2016
61
0.040
 Why?
Socioeconomic Factors
1
2017
364
0.040
 Why?
Cholesterol, LDL
1
2016
46
0.040
 Why?
Current Procedural Terminology
1
2015
14
0.040
 Why?
MEDLINE
1
2015
7
0.030
 Why?
Up-Regulation
1
2016
225
0.030
 Why?
Germany
1
2014
13
0.030
 Why?
Learning Curve
1
2014
21
0.030
 Why?
Phantoms, Imaging
1
2014
45
0.030
 Why?
Materials Testing
1
2014
143
0.030
 Why?
Tomography, X-Ray Computed
1
2019
899
0.030
 Why?
Longitudinal Studies
1
2018
1485
0.030
 Why?
Postoperative Complications
1
2019
1117
0.030
 Why?
Clinical Competence
1
2014
284
0.030
 Why?
Intra-Abdominal Fat
1
2010
48
0.020
 Why?
Hypertension
1
2010
293
0.020
 Why?
Motor Activity
1
2010
391
0.020
 Why?
Doukky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (381) concept(s)
_
Co-Authors Expand Description
See all (26) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department